Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1005091]Researchers: Dr Judy Tellam (Principal investigator)
Brief description Epstein-Barr virus, (EBV) is a human herpesvirus associated with a range of human cancers. EBNA1, an important EBV antigen, was thought to be “immunologically silent” however, recent studies from our laboratory show that EBNA1 is recognized by our body's defence system and these observations raise the possibility that EBNA1 may be an exploitable, immuno-therapy target for treating EBV-associated cancers.
Funding Amount $AUD 356,513.15
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1005091
- PURL : https://purl.org/au-research/grants/nhmrc/1005091
